The Pfizer Covid vaccine increased the risk of heart problems for children sixfold in the first week of having the jab but ...

Taking a closer look at the numbers, Comirnaty sales slipped 19% globally to $1.15 billion, the Prevnar franchise experienced a 3% global sales decline to $1.7 billion, and Abrysvo’s performance ...

The new Moderna COVID vaccine, mNexspike, is approved for adults 65 and older and people 12 to 64 with an underlying medical ...

Children, young people were more likely to experience heart, vascular or inflammatory problems after a COVID-19 infection ...

The vaccination campaign comes as COVID-19 cases in people going to emergency or urgent care for respiratory symptoms have increased. About 10 per cent of tests were positive for the week ending Sept.

Pfizer also has set its sights on becoming a giant in oncology, and to support this, completed the acquisition of Seagen in 2023. Two of Seagen's products in the most recent quarter delivered ...

Pfizer raised its 2025 profit forecast for the second time this year, as ongoing cost cuts helped make up for slow sales ...

Sept 15 (Reuters) - Pfizer Inc (PFE.N), opens new tab said on Tuesday participants were showing mostly mild-to-moderate side effects when given either the company's experimental coronavirus ...

Vertex should earn other important approvals through 2030 that could jolt its stock price. It's developing a treatment called ...

The new study, spearheaded by experts at UCL and the universities of Cambridge and Edinburgh, with support from the BHF Data ...